# Daxor Corp: financial statements, quarterly

DXR · Nasdaq · CIK 27367 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dxr.md) · [Financials](/companies/dxr/financials.md) · [Filings](/companies/dxr/filings.md) · [Insiders](/companies/dxr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dxr/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2010-06-30) | period not labelled (2010-09-30) | period not labelled (2010-12-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | Q4 FY2011 (2011-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [368](/filings/0001019056-11-000884.md) | [453](/filings/0001019056-11-001087.md) | [361 d](/filings/0001019056-12-000401.md) | [358](/filings/0001019056-11-000884.md) | [341](/filings/0001019056-11-001087.md) | [370 d](/filings/0001019056-12-000401.md) |
| Cost of revenue | $k | [165](/filings/0001019056-11-000884.md) | [186](/filings/0001019056-11-001087.md) | [185 d](/filings/0001019056-12-000401.md) | [161](/filings/0001019056-11-000884.md) | [149](/filings/0001019056-11-001087.md) | [177 d](/filings/0001019056-12-000401.md) |
| Gross profit | $k | [203](/filings/0001019056-11-000884.md) | [268](/filings/0001019056-11-001087.md) | [177 d](/filings/0001019056-12-000401.md) | [197](/filings/0001019056-11-000884.md) | [192](/filings/0001019056-11-001087.md) | [193 d](/filings/0001019056-12-000401.md) |
| Research and development | $k | [735](/filings/0001019056-11-000884.md) | [695](/filings/0001019056-11-001087.md) | [720 d](/filings/0001019056-12-000401.md) | [670](/filings/0001019056-11-000884.md) | [637](/filings/0001019056-11-001087.md) | [710 d](/filings/0001019056-12-000401.md) |
| Selling, general and administrative | $k | [973](/filings/0001019056-11-000884.md) | [858](/filings/0001019056-11-001087.md) | [983 d](/filings/0001019056-12-000401.md) | [871](/filings/0001019056-11-000884.md) | [816](/filings/0001019056-11-001087.md) | [489 d](/filings/0001019056-12-000401.md) |
| Operating income | $k | [(1,505)](/filings/0001019056-11-000884.md) | [(1,285)](/filings/0001019056-11-001087.md) | [(1,527) d](/filings/0001019056-12-000401.md) | [(1,344)](/filings/0001019056-11-000884.md) | [(1,261)](/filings/0001019056-11-001087.md) | [(1,006) d](/filings/0001019056-12-000401.md) |
| Interest expense | $k | [8.9](/filings/0001019056-11-000884.md) | [20.3](/filings/0001019056-11-001087.md) | not reported | [81.3](/filings/0001019056-11-000884.md) | [29.8](/filings/0001019056-11-001087.md) | not reported |
| Income tax | $k | [(39.9)](/filings/0001019056-11-000884.md) | [1,799](/filings/0001019056-11-001087.md) | [1,039 d](/filings/0001019056-12-000401.md) | [(182)](/filings/0001019056-11-000884.md) | [(2,845)](/filings/0001019056-11-001087.md) | [(1,055) d](/filings/0001019056-12-000401.md) |
| Net income | $k | [188](/filings/0001019056-11-000884.md) | [2,605](/filings/0001019056-11-001087.md) | [2,268 d](/filings/0001019056-12-000401.md) | [(185)](/filings/0001019056-11-000884.md) | [(4,184)](/filings/0001019056-11-001087.md) | [(1,491) d](/filings/0001019056-12-000401.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001019056-11-000884.md) | [0.62](/filings/0001019056-11-001087.md) | not reported | [(0.04)](/filings/0001019056-11-000884.md) | [(0.99)](/filings/0001019056-11-001087.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted

## Balance sheet

| Line item | Unit | period not labelled (2009-12-31) | period not labelled (2010-06-30) | period not labelled (2010-09-30) | period not labelled (2010-12-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | FY2011 (2011-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.3](/filings/0001019056-12-000401.md) | [0.2](/filings/0001019056-11-000884.md) | [0.1](/filings/0001019056-11-001087.md) | [0.1](/filings/0001019056-12-000401.md) | [0.1](/filings/0001019056-11-000884.md) | [0.0](/filings/0001019056-11-001087.md) | [0.1](/filings/0001019056-12-000401.md) |
| Current assets | $m | not reported | not reported | not reported | [87.0](/filings/0001019056-12-000401.md) | [92.1](/filings/0001019056-11-000884.md) | [84.1](/filings/0001019056-11-001087.md) | [81.7](/filings/0001019056-12-000401.md) |
| Total assets | $m | not reported | not reported | not reported | [91.2](/filings/0001019056-12-000401.md) | [96.2](/filings/0001019056-11-000884.md) | [88.3](/filings/0001019056-11-001087.md) | [85.7](/filings/0001019056-12-000401.md) |
| Current liabilities | $m | not reported | not reported | not reported | [43.9](/filings/0001019056-12-000401.md) | [50.4](/filings/0001019056-11-000884.md) | [50.4](/filings/0001019056-11-001087.md) | [49.3](/filings/0001019056-12-000401.md) |
| Total liabilities | $m | not reported | not reported | not reported | [44.2](/filings/0001019056-12-000401.md) | [50.7](/filings/0001019056-11-000884.md) | [50.6](/filings/0001019056-11-001087.md) | [49.5](/filings/0001019056-12-000401.md) |
| Shareholders' equity | $m | [47.6](/filings/0001019056-12-000401.md) | not reported | not reported | [47.0](/filings/0001019056-12-000401.md) | [45.6](/filings/0001019056-11-000884.md) | [37.6](/filings/0001019056-11-001087.md) | [36.2](/filings/0001019056-12-000401.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2010-09-30) | period not labelled (2010-12-31) | Q3 FY2011 (2011-09-30) | Q4 FY2011 (2011-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,223) d](/filings/0001019056-11-001087.md) | [(1,835) d](/filings/0001019056-12-000401.md) | [(613) d](/filings/0001019056-11-001087.md) | [(990) d](/filings/0001019056-12-000401.md) |
| Capital expenditure | $k | [90.6 d](/filings/0001019056-11-001087.md) | [35.0 d](/filings/0001019056-12-000401.md) | [58.2 d](/filings/0001019056-11-001087.md) | [4.7 d](/filings/0001019056-12-000401.md) |
| Dividends paid | $k | [1,058 d](/filings/0001019056-11-001087.md) | [2,747 d](/filings/0001019056-12-000401.md) | [0.0 d](/filings/0001019056-11-001087.md) | [421 d](/filings/0001019056-12-000401.md) |
| Share repurchases | $k | not reported | not reported | [0.1 d](/filings/0001019056-11-001087.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 4,196,182 at 2012-03-22, from the cover of the [10-K filed 2012-03-28](/filings/0001019056-12-000401.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.